Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PQR309 in Progressive Glioblastoma
NCT02850744Phase 2Terminated
- Sponsor
- PIQUR Therapeutics AG
- Start
- Jul 2015
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
A Phase 2 trial of bimiralisib in glioblastoma multiforme (GBM), sponsored by PIQUR Therapeutics AG. Started Jul 2015; status: terminated.
02
Drugs
bimiralisib
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT02850744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02850744.